No Detail Found!

Comparative and combination study of Simvastatin alone and in combination with Beta vulgaris in hyperlipidemia patients

Author(s)
Nadeem Ahmed Shaikh Department Pharmacology, Baqai Medical University Karachi,Karachi,Pakistan
Shamaila Khakid Department Pharmacology Dow Medical College DUHS Karachi,Karachi,Pakistan
Mahboob Alam Department Pharmacology Basic Medical Sciences Institute,JPMC, Karachi,Pakistan
Syed Saud Hasan Department Pharmacology, Dow Medical College DUHS Karachi,Karachi,Pakistan
Fatima Rizvi Department Pharmacology, Dow International Medical College, DUHS Karachi,Karachi,Pakistan
Khadija Mobeen Department of Surgery, Dow University Hospital Karachi,Karachi,Pakistan
Abstract
Phytomedicine is gaining acceptance as well preference in health care management for various diseases. Drug combinations are mostly used clinically for hyperlipidemia, as single-agent therapy is insufficient. Statins remain the cornerstone of hyperlipidemia. The objective of the present research is to manage hyperlipidemia with the least amount of medicine effective clinically, thereby limiting its side effects. Study was carried out with 140 registered hyperlipidemia patients, divided into two groups. Group-A received simvastatin 20mg oral daily & Group B received a combination of simvastatin and beta-valgaris capsules twice a day for 90 days. Pre and post treatment values were compared within the groups and between the groups. Group B shows statistically significant decrease (p<0.05) in serum total cholesterol, low density lipoprotein (LDL), triglycerides (TG) and CRP levels. Also significant improvement (p<0.05) was noted for high density lipoprotein (HDL) levels (20.1% to 57.4%) in group B after completion of study. On the basis of our study results, we can conclude that statins remained to be the mainstay treatment for patients with elevated cholesterol levels. However, the combination has a synergistic effect and reduces oxidative stress (OS) as well.
Publication Details
Page(s) 1033-1041
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Simvastatin, C reactive protein, CRP, cap Beta-vulgaris, lipid fraction
0

Citations

0

Downloads

154

Views